Overview

Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy

Status:
Unknown status

Trial end date:
2017-10-01

Target enrollment:

Participant gender:

Summary

This study is to compare the pharmacodynamics of a Fixed Dose Combination Pill AAR (acetylsalicylic acid 100 mg, atorvastatin 40 mg and ramipril 10 mg) and the respective reference products, atorvastatin (Lipitor®) 40 mg and ramipril (Altace®) 10 mg.

Phase:

Phase 2

Details

Lead Sponsor:

Ferrer Internacional S.A.

Treatments:

Aspirin
Atorvastatin
Atorvastatin Calcium
Ramipril